Literature DB >> 27664932

MicroRNA 182 inhibits CD4+CD25+Foxp3+ Treg differentiation in experimental autoimmune encephalomyelitis.

Cong Wan1, Chang-Yun Ping2, Xiao-Yu Shang3, Jiang-Tian Tian4, Si-Han Zhao2, Lei Li5, Shao-Hong Fang4, Wei Sun6, Yan-Feng Zhao5, Zhao-Ying Li2, Yan-Wen Xu2, Li-Li Mu2, Jing-Hua Wang2, Qing-Fei Kong2, Guang-You Wang2, Hu-Lun Li7, Bo Sun8.   

Abstract

MicroRNA 182 has been found to have a distinct contribution in the clonal expansion of activated- and functioning of specialized-helper T cells. In this study we knocked down microRNA 182 in vivo and induced experimental autoimmune encephalomyelitis (EAE) to determine the influences of microRNA 182 in the Treg cells functional specialization through Foxo1 dependent pathway in the peripheral lymphoid organs. Down-regulation of microRNA 182 significantly increased the proportions of Foxp3+ T cells in the peripheral lymph nodes and spleen. In vivo study verified a positive correlation between microRNA 182 levels and symptom severity of EAE, and a negative correlation between microRNA 182 and the transcriptional factor Foxp3. In vitro polarization study also confirmed the contribution of Foxo1 in microRNA 182 mediated down-regulation of Foxp3+ T cells. Together, our results provide evidence that during the development of EAE, microRNA 182 repressed Treg cells differentiation through the Foxo1 dependent pathway. Copyright Â
© 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Experimental autoimmune encephalomyelitis; Foxo1; MicroRNA 182; Treg cells

Mesh:

Substances:

Year:  2016        PMID: 27664932     DOI: 10.1016/j.clim.2016.09.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

Review 1.  MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease.

Authors:  Cuilian Liu; Haoran Yang; Weiyun Shi; Ting Wang; Qingguo Ruan
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

Review 2.  miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes.

Authors:  Martin G Scherm; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2020-07-28       Impact factor: 4.810

Review 3.  Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.

Authors:  Patrizia Fasching; Martin Stradner; Winfried Graninger; Christian Dejaco; Johannes Fessler
Journal:  Molecules       Date:  2017-01-14       Impact factor: 4.411

Review 4.  miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes.

Authors:  Martin G Scherm; Carolin Daniel
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555

5.  miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus.

Authors:  Shaolan Zhou; Jing Zhang; Pengfei Luan; Zhanbing Ma; Jie Dang; Hong Zhu; Qian Ma; Yanfeng Wang; Zhenghao Huo
Journal:  J Immunol Res       Date:  2021-05-06       Impact factor: 4.818

6.  Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis.

Authors:  Aya A Elkhodiry; Hend M El Tayebi
Journal:  Noncoding RNA Res       Date:  2021-12-07

7.  microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.

Authors:  Mai Fujiwara; Radhika Raheja; Lucien P Garo; Amrendra K Ajay; Ryoko Kadowaki-Saga; Sukrut H Karandikar; Galina Gabriely; Rajesh Krishnan; Vanessa Beynon; Anu Paul; Amee Patel; Shrishti Saxena; Dan Hu; Brian C Healy; Tanuja Chitnis; Roopali Gandhi; Howard L Weiner; Gopal Murugaiyan
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

8.  Deletion of microRNA-183-96-182 Cluster in Lymphocytes Suppresses Anti-DsDNA Autoantibody Production and IgG Deposition in the Kidneys in C57BL/6-Faslpr/lpr Mice.

Authors:  Zhuang Wang; Bettina Heid; Ran Lu; Mohit Sachdeva; Michael R Edwards; JingJing Ren; Thomas E Cecere; Deena Khan; Taschua Jeboda; David G Kirsch; Christopher M Reilly; Rujuan Dai; S Ansar Ahmed
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.